pharma R&D

Productivity in Biopharma Research Picks Up

Technological developments in the pharmaceutical and biotech industry are reflected in increased funding, higher R&D productivity and more product launches. However, the general conditions remain challenging. Incremental change won’t be enough to deliver the results that the market and patients demand, warn industry experts.

Devalued and Distrusted

Ashland to Expand Pharmaceutical Center of Excellence in Delaware

After Tech Success, Israel Seeks Life Sciences Growth

GSK Bets on Chimp Virus with $321 Million Vaccines Buy

New J&J Anti-depressant Related to "Special K" Party Drug

Pfizer Takes its Shot at a Vaccine for Evasive Superbug

U.S. Government Taps GlaxoSmithKline for New Antibiotic

Aesica Enters Research Collaboration with University of Nottingham

Big Drugmakers Think Small with Nanomedicine Deals

Sanofi to Step Up Development of New Diabetes Device

Court Stops EU Regulator Releasing Drug Company Data

New Gene Therapy Trials Aim to Mend Broken Hearts

Merck, Pfizer to Jointly Develop Diabetes Drug

South Africa Seeks to Close Drug Patent Loophole

AstraZeneca Bets on Nanotech with Bind Therapeutics Deal

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

New Technology Speeding Progress on Bird Flu Vaccine

GSK Plans $1 Million Prize to Jump-start "Electroceuticals"

Bristol-Myers Names Cuss to Replace Sigal as R&D Chief

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Roche Stays a Step Ahead of Copycat Drugmakers

Antibiotics Crisis Prompts Rethink on Risks, Rewards

GlaxoSmithKline Boss Says New Drugs Can Be Cheaper

Merck Veteran Named R&D Chief, After Drug Setbacks

Ashland to Expand Pharmaceutical Center of Excellence in Delaware

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Slow Approvals Put India's Drug Trials Industry at Risk

Regeneron Says Sanofi to Boost Stake in its Shares

Amgen Biosimilar Push Takes Aim at Blockbusters

Drugmakers, Academics Pool R&D in $265 Million EU Project

Revived Search for a TB Vaccine May Be About to Pay Off

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

Drug Industry Bets on New Blockbusters in 2013